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Development/Plasticity/Repair
Selective Activation of Microglia Facilitates Synaptic
Strength
XAnna K. Clark,1,2 Doris Gruber-Schoffnegger,1 XRuth Drdla-Schutting,1 Katharina J. Gerhold,1 Marzia Malcangio,2
and X Ju¨rgen Sandku¨hler1
1Department of Neurophysiology, Center for Brain Research, Medical University of Vienna, A-1090 Vienna, Austria, and 2Wolfson Centre for Age Related
Diseases, King’s College London, London SE1 1UL, United Kingdom
Synaptic plasticity is thought to be initiated by neurons only, with the prevailing view assigning glial cells mere specify supportive
functions for synaptic transmission and plasticity. We now demonstrate that glial cells can control synaptic strength independent of
neuronal activity. Herewe show that selective activation ofmicroglia in the rat is sufficient to rapidly facilitate synaptic strength between
primary afferent C-fibers and lamina I neurons, the first synaptic relay in the nociceptive pathway. Specifically, the activation of the
CX3CR1 receptor by fractalkine induces the release of interleukin-1 frommicroglia, whichmodulates NMDA signaling in postsynaptic
neurons, leading to the release of an eicosanoidmessenger, which ultimately enhances presynaptic neurotransmitter release. In contrast
to the conventional view, this form of plasticity does not require enhanced neuronal activity to trigger the events leading to synaptic
facilitation. Augmentation of synaptic strength in nociceptive pathways represents a cellular model of pain amplification. The present
data thus suggest that, under chronic pain states, CX3CR1-mediated activation of microglia drives the facilitation of excitatory synaptic
transmission in the dorsal horn, which contributes to pain hypersensitivity in chronic pain states.
Key words: chemokine; chronic pain; fractalkine; microglia; spinal cord; synaptic plasticity
Introduction
Synaptic plasticity is classically regarded as a hallmark of neurons,
requiring both presynaptic and postsynaptic neuronal mecha-
nisms (Bliss and Collingridge, 1993; Malenka and Bear, 2004).
Glial cells participate in synaptic transmission; however, while
neuron–glia communication is necessary for synaptic plasticity
(Gruber-Schoffnegger et al., 2013; Ji et al., 2013; Xanthos and
Sandku¨hler, 2014), it is considered to play amere supportive role
(Ben Achour and Pascual, 2010). Astrocyte modulation of plastic-
ity is evident; the role of microglia is less clear. Microglia release
proinflammatorymediators and gliotransmitters that canmodulate
synaptic transmission (Kawasaki et al., 2008; Gruber-Schoffnegger
et al., 2013); however, these factors also originate from other cell
types, including astrocytes. Thus, it is currently unknown whether
microglia alone are sufficient to modify synaptic strength.
Peripheral damage results in maladaptive augmentation of
responses to noxious stimuli at the first nociceptive synapse, be-
tween primary afferent C-fibers and dorsal horn neurons. Long-
term potentiation (LTP) at C-fiber synapses is a cellular model of
injury-induced hypersensitivity (Ikeda et al., 2003; Ikeda et al.,
2006; Sandku¨hler, 2009; Zhong et al., 2010; Park et al., 2011) and
involves many signal transduction pathways, such as NMDA re-
ceptor activation. These same transduction mechanisms are es-
sential for the development of hypersensitivity in models of
chronic pain, suggesting that LTP andbehavioral hypersensitivity
share many common mechanisms (Sandku¨hler, 2009). Impor-
tantly, microglia activity is required for activity-dependent LTP
in the dorsal horn and the pronociceptive cytokines interleukin
(IL)-1 and tumor necrosis factor (TNF), which can be released
bymicroglia, and canmodify synaptic transmission at spinal syn-
apses (Kawasaki et al., 2008; Zhong et al., 2010; Gruber-
Schoffnegger et al., 2013).
Neuron–microglia communication in the spinal cord dorsal
horn is vital for the modulation of nociceptive transmission fol-
lowing peripheral damage (Clark and Malcangio, 2012; Ji et al.,
2013). A greater understanding of neuron–microglia interactions
during chronic pain states has led to the identification of new
therapeutic targets, including chemokine receptors such as
CX3CR1 (Clark et al., 2011; Clark and Malcangio, 2012). The
G-protein-coupled receptor CX3CR1 and its ligand fractalkine
(FKN) represent a key signaling pair for neuron–microglia com-
munication in the spinal cord (Clark et al., 2011); CX3CR1 is
exclusively expressed by microglia, where it mediates the effect
of the neuronal chemokine FKN. Thus, FKN is a unique tool for
the specific stimulation of microglia. In chronic pain states,
CX3CR1-expressing spinal microglia respond to soluble FKN by
intracellular p38 mitogen-activated protein kinase (MAPK)
phosphorylation (Clark et al., 2007; Zhuang et al., 2007) and the
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release of proinflammatory mediators (Milligan et al., 2004;
Clark et al., 2009), which induce pain hypersensitivity. Microglia
released cathepsin S (CatS) is responsible for FKN cleavage from
neurons into chemokine domain-containing pronociceptive
fragments (Clark and Malcangio, 2012). The therapeutic poten-
tial for disruption of FKN/CX3CR1 signaling is widespread; in-
hibition of CX3CR1 signaling reverses chronic pain behaviors,
and CX3CR1-null mice do not develop pain hypersensitivity
(Clark and Malcangio, 2014).
Herewe investigatedwhether specific activation ofmicroglia, via
the CX3CR1 receptor, is sufficient to induce an amplification of
synaptic strength at the first synapse in the nociceptive pathway and
themechanisms bywhich specificmicroglial signaling pathways can
dynamically modulate nociceptive synaptic strength.
Materials andMethods
All procedures were in accordance with EuropeanCommunities Council
directives (86/609/EEC) and United KingdomHome Office regulations.
In vitro electrophysiology
Spinal cord slice preparation. Transverse spinal cord slices with dorsal
roots attached were made from young male Sprague Dawley rats (age
range, 25–30 d) as previously described (Ikeda et al., 2003, 2006; Gruber-
Schoffnegger et al., 2013). Briefly, the spinal cord was quickly removed
into ice-cold incubation solution consisting of the following (in mM): 95
NaCl, 1.8 KCl, 1.2 KH2PO4, 0.5 CaCl2, 7 MgSO4, 26 NaHCO3, 15 glu-
cose, and 50 sucrose, pH 7.4, with measured osmolarity of 310–320
mOsm/L, oxygenated with 95%O2 and 5%CO2. The duramater and the
ventral roots were then removed. Transverse slices (500 m thick)
from segments L2–L6 with dorsal roots (10–15 mm) attached were cut
using a vibrating microslicer (DTK-1000, Dosaka EM). Slices were kept
in the incubation solution at 32°C for at least 30 min, after which they
were stored in the same solution at room temperature (20–24°C).
Patch-clamp recordings. A single slice was placed in the recording
chamber and continuously superfused with oxygenated recording solu-
tion at a rate of 3–4 ml/min. The recording solution was identical to the
incubation solution except for the following (in mM): 127 NaCl, 2.4
CaCl2, 1.3 MgSO4, and 0 sucrose. All recordings were made at 32 1°C.
Neurons of the dorsal horn were visualized with “Dodt” infrared optics
(Dodt and Zieglga¨nsberger, 1990) using a 40, 0.80 water-immersion
objective on an Olympus BX50WI upright microscope equipped with a
video camera. Lamina I neurons were recorded in the whole-cell patch-
clamp configuration. Only neurons at a distance of 20 m from the
dorsal white/gray matter border were considered as being lamina I neu-
rons and were used for experiments. Patch pipettes (2–4 M) from
borosilicate glass (Hilgenberg) were pulled on a horizontal puller (P-87,
Sutter Instruments). The internal pipette solution consisted of the fol-
lowing (in mM): 120 potassium gluconate, 20 KCl, 2 MgCl2, 2 Na2ATP,
0.5 NaGTP, 20 HEPES, and 0.5 EGTA, pH adjusted to 7.28 with KOH,
withmeasured osmolarity of 300mOsm/L. Themembrane potential was
measured immediately after establishing the whole-cell configuration,
and neurons with amembrane potential less negative than45mVwere
not analyzed further. All recordings were made at a holding potential
of 75 mV using an Axopatch 200B patch-clamp amplifier and the
pCLAMP version 10 software package (bothMolecular Devices). Signals
were low-pass filtered at 2–10 kHz, sampled at 10–20 kHz, and analyzed
off-line using pCLAMP version 10. No correction for the liquid junction
potential was made.
Afferent-evoked EPSCs in lamina I neurons were elicited by stimulat-
ing dorsal roots electrically via a suction electrode with an isolated
current stimulator (A360, World Precision Instruments). After determi-
nation of the threshold needed to elicit an EPSC, stimulus intensity was
adjusted to 200% of the threshold value, and test pulses of 0.1 ms were
given at intervals of 30 s for C-fiber signals, and of 15 s for A-fiber
signals. EPSCs were classified as being C-fiber-evoked when the calcu-
lated conduction velocity was 0.5 m/s, and as being A-fiber-evoked
when the calculated conduction velocity was 1.5 m/s. Monosynaptic
input was identified by the absence of failures in response to 10 stimuli at
2 Hz (for C-fiber input) or at 10 Hz (A-fiber input), and a jitter in
response latencies of 10% of the response delay. Measurements were
made from only one neuron per spinal cord slice in all experiments
performed. Series resistance was monitored throughout the experiment.
Neurons were discarded if the series resistance changed by20% during
the experiment.
Drug application. Drugs were applied to the bath solution at known
concentrations. Bicuculline (10 M; Sigma-Aldrich) and strychnine (4
M; Sigma-Aldrich) were included in the recording solution for all ex-
periments. In addition, tetrodotoxin (TTX; 1 M; Abcam) was added to
the recording solution during some experiments to measure miniature
EPSCs (mEPSCs). Rat recombinant FKN (amino acids 25–100; 200 ng/
ml; R&D systems) was applied in the presence and absence of a range of
pharmacological agents, as follows: FKN neutralizing antibody (anti-
FKN; 2g/ml for 1 h preincubation then 1g/ml for the duration of the
recording; R&D systems); control goat IgG (IgG; 2 g/ml for 1 h prein-
cubation then 1 g/ml for the duration of the recording; R&D systems);
minocycline (100 M for 90 min preincubation then 20 M for duration
of the recording; Sigma-Aldrich); IL-1 receptor antagonist (IL-1ra; 40
ng/ml for 20 min preincubation and the duration of the recording; AbD
Serotec); soluble TNF receptor (sTNF R1; 0.5g/ml for 20 min preincu-
bation and the duration of the recording; R&D Systems); D-amino acid
oxidase (D-AAO; 0.2 U/ml for 1 h preincubation and the duration of the
recording; Sigma-Aldrich); 2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-
imidazoline-1-oxyl-3-oxide (cPTIO; 30 M for 30 min preincubation
and the duration of the recording; Tocris Bioscience); N-[[3-(amino-
methyl)phenyl]methyl]-ethanimidamide dihydrochloride (1400W; 3
M for 30 min preincubation and the duration of the recording; Tocris
Bioscience); or arachidonyl trifluoromethyl ketone (AACOCF3; 10 M
for 20 min preincubation then for the duration of the recording; Tocris
Bioscience). AACOCF3 was initially dissolved in dimethylsulfoxide
(DMSO) and then diluted to a final concentration in the recording solu-
tion. Thus, control experiments were performed in the presence of
DMSO (0.05% final concentration) under the same experimental condi-
tions as AACOCF3 (20 min preincubation then for the duration of the
recording). All other compoundswere dissolved directly in the recording
solution. Drug-free experiments, in which FKN was applied alone (all
shown in Fig. 1B), were interleaved with experiments using the drug
application. In addition, control experiments were performed in the
presence of each pharmacological agent, but in the absence of FKN.
In other experiments, compounds were included in the pipette solu-
tion alone to specifically block postsynaptic signaling mechanisms.
The selectiveNMDAreceptor blocker (	)-5-methyl-10,11-dihydro-5H-
dibenzo[a,d]cyclohepten-5,10-imine maleate (MK801; 1 mM; Tocris
Bioscience) was added to the standard pipette solution (Humeau et al.,
2003; Bender et al., 2006; Naka et al., 2013). In further experiments,
the Ca2	 chelator bis(2-aminophenoxy)ethane-N,N,N
,N
-tetra-acetic
acid (BAPTA; 20 mM; Sigma-Aldrich) was added to the pipette solution
consisting of the following (in mM): 80 potassium gluconate, 20 KCl, 2
MgCl2, 2 Na2ATP, 0.5 NaGTP, 20 HEPES, and 0.5 EGTA, pH 7.28 with
KOH, andmeasured osmolarity of 300mOsm/L. In both cases, recording
was initiated 15 min after whole-cell patch was achieved to allow full
diffusion of MK801/BAPTA within the postsynaptic neuron.
Retrograde labeling of projection neurons. Young (age range, 21–24 d)
male Sprague Dawley rats were deeply anesthetized with a mixture of
ketamine and xylazine (9:1; 3.4 ml/kg) and placed in a stereotaxic appa-
ratus. A hole was drilled through the skull for insertion of a 500 nl Ham-
ilton syringe needle (0.51 mm outer diameter). Two injections of 20 nl
(40 nl total volume) of 2.5% 1,1
-dioctadecyl-3,3,3
,3
-tetramethylindo-
carbocyanine perchlorate (DiI), separated by 1 min, were made into the
right side of the periaqueductal gray (PAG) according to the atlas of
Paxinos andWatson (1982). After recovery from anesthesia, the animals
fed and drank normally. Three to four days following injection, lumbo-
sacral segments of the spinal cordwere excised and transverse spinal cord
slices were prepared as described above. The brain of each injected rat
was removed, and the injection site was verified by microscopy. Follow-
ing confirmation of an accurate PAG injection, projection neurons were
identified in the slice by DiI labeling.
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Data analysis. Synaptic strength was quanti-
fied by measuring the amplitude of monosyn-
aptic EPSCs. Amplitudes were calculated by
subtracting the baseline from the peak ampli-
tude. Themean amplitude of six EPSCs evoked
by test stimuli served as a control period. The
effects of FKN were quantified as a percentage
change in EPSC amplitude, comparing the am-
plitudes of the last six EPSCs to the control
period. The synaptic strength of each individual
neuron was assessed statistically at several time
points (pre-FKNvs 10, 20, and 30min after FKN
application) using a one-way ANOVA. Neu-
rons that exhibited a statistically significant
(p  0.05) change of synaptic strength (com-
pared with their own baseline) were classified
as FKN responders. Neurons that did not
exhibit a statistically significant change in syn-
aptic strength were classified as FKN nonre-
sponders. Two pulses were given with an
interstimulus interval of 200 ms. The paired-
pulse ratio (PPR) was determined by dividing
the amplitude of the second EPSC by the am-
plitude of the first EPSC and averaging over 3
min epochs of six EPSCs. The squared coeffi-
cient of variation [CV2 (CV2  mean2/
variance)] was calculated for 3 min epochs of
six EPSCs and normalized to the control pe-
riod. Spontaneous EPSCs (sEPSCs) and
mEPSCs were counted and analyzed off-line
using MiniAnalysis software (Synaptosoft).
sEPSCs and mEPSCs were analyzed only in
neurons with a noise level of 3.5 pA. Each
sEPSC/mEPSC event was visually accepted or
rejected based upon the rise and decay times
after an automatic screening by the software.
In vivo electrophysiology
Field potential recordings. Experiments were
performed in adult male Sprague Dawley rats.
Isoflurane in two-thirds N2O and one-thirdO2
was used to induce [4 volume percent (vol%)
inspiratory] and maintain (1.5 vol% expira-
tory) anesthesia. Concentrations of gases were
measured and monitored with a capnograph
(CapnomacUltima, Datex-Ohmeda). The sur-
gical level of anesthesia was verified by stable
arterial blood pressure and by the absence of a
Figure 1. FKN induces rapid enhancement of synaptic transmission. A, B, Iba-1 (red) and p-p38 MAPK (green; colocalization
with Iba-1, yellow) immunoreactivity in the dorsal horn of control (A) and FKN (B) spinal cord slices. Scale bar, 50m. C, In seven
neurons tested, C-fiber-evoked EPSC amplitude stays constant over a recording period of 40min ( p 0.05, one-way RMANOVA).
D, FKN (200 ng/ml for 30 min, black bar) induced a significant facilitation of C-fiber-evoked EPSC amplitude in 18 of 31 neurons
tested [134 6% at 30 min, p 0.001, one-way RM ANOVA; p 0.01 compared with control neurons (C), Fisher’s exact test].
Filled circles represent neurons showing statistically significant facilitation ( p 0.05, one-way RM ANOVA; FKN Responders);
open cycles, neurons showing no change after FKN application ( p 0.05, one-way RMANOVA; FKNNonresponders). Insets show
4
individual EPSC traces recorded froma FKN responding neuron
at the indicated timepoints.E,F, Facilitationof C-fiber-evoked
EPSC by FKN is associatedwith a decrease in the PPR (E) and an
increase in the CV2 value (F) compared with pretreatment
values (*p 0.05, **p 0.01, one-way RM ANOVA). G, H,
FKNapplication is associatedwith an increase in thenumber of
sEPSCs [G; 148 10% at 10 min, 157 21% at 20 min after
FKN (n 11)] andmEPSCs [H; 139 18% at 10min, 173
22% at 20 min after FKN (n 10)] compared with pretreat-
ment values (**p  0.01, ***p  0.001, one-way RM
ANOVA). Insets show representative traces of sEPSCs. I, In
seven neurons tested, A-fiber-evoked EPSC amplitude stays
constant over a recording period of 40 min ( p 0.05, one-
way RM ANOVA). J, FKN (200 ng/ml for 30 min, black bar) did
not modify A-fiber-evoked EPSC amplitude in 12 neurons
tested [89 5% at 30 min, p 0.05, one-way RM ANOVA;
p 0.05 compared with control neurons (I), Fisher’s exact
test].
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reflex during pinching the interdigital area of the forepaw. Animals were
intubated with a 14 ga cannula for mechanical ventilation with a respi-
rator (Servo Ventilator 900C, Siemens). The right femoral artery and
vein were then cannulated with a polyethylene catheter to continuously
monitor blood pressure and to allow infusions of intravenous solutions.
During anesthesia, animals continuously received an intravenous solu-
tion (58% Ringer’s solution, 30% HAES, 8% glucose, and 4% sodium
bicarbonate, 2 ml/h) for stabilization of blood pressure (mean, 130–160
mmHg), and base excess (mean,1.5 0.8 mmol/L). The arterial cath-
eter was flushed every 30 min with a heparinized sodium solution (2.5
IU/ml) to prevent blood agglutination. Arterial blood gas analyses were
performed every 30min. Colorectal temperature was kept at37°Cwith
a feedback-controlled heating blanket (Panlab). The left sciatic nerve was
dissected free for bipolar stimulation with a silver hook electrode. The
electrode was then isolated from surroundingmuscles with a plastic film.
A laminectomy was performed to expose lumbar segments four and five
(L4–L5). Twometal clampswere used for fixation of the animal vertebral
column in a stereotactic frame. An agarose pool was formed around the
exposed spinal segments. The exposed part of the sciatic nerve was cov-
ered with warm paraffin oil. Muscle relaxation was achieved by intrave-
nous injection of 2g/kg/h pancuronium bromide. Electrophysiological
recordings were performed as previously described (Drdla et al., 2009;
Drdla-Schutting et al., 2012; Gruber-Schoffnegger et al., 2013). Briefly,
C-fiber-evoked field potentials were recorded with glass electrodes (im-
pedance, 2–3M) from lamina I and II of the spinal cord dorsal horn in
response to the stimulation of sciatic nerve fibers. The pipette solution
consisted of the following (in mM): 135 NaCl, 5.4 KCl, 1.8 CaCl2, 10
HEPES, 1 MgCl2, and 0.2% rhodamine B (Sigma-Aldrich). Electrodes
were driven by a microstepping motor. Recordings were made with an
ISODAM amplifier (ISO-STIM 01D, npi electronic) using a bandwidth
filter of 0.1–1000 Hz. Signals were monitored on a digital oscilloscope
and digitized by an analog-to-digital converter. Afferent input from the
hindpaw was identified by mechanical stimulation of the foot while
acoustically evaluating the evoked responses with an audiomonitor. Test
stimuli were delivered to the sciatic nerve and consisted of single pulses of
0.5 ms at an intensity of 25 V given every 5 min using an electrical
stimulator. Rat recombinant FKN (amino acids 25–100; 200 ng/ml; R&D
systems), anti-CX3CR1 (rabbit anti-CX3CR1; 60 g/ml; Torrey Pines
Institute for Molecular Studies), and control IgG (rabbit IgG; 60 g/ml)
were dissolved in artificial CSF to obtain the desired concentrations and
were applied directly onto the spinal cord dorsum. At the end of each
electrophysiological experiment, pressure was applied to the electrode
(300 mbar for 1 min) for marking the recording site with rhodamine B.
Data analysis. The area under the curve of C-fiber-evoked field poten-
tials was determined off-line using Clampfit version 10. The mean area
under the curve of at least six consecutive field potentials before FKN
application served as a control period. Responses were normalized for
each rat.
Release of IL-1 from dorsal horn slices
Dorsal horn slice preparation. Horizontal dorsal horn slices with dorsal
roots attached were obtained, as previously described (Clark et al., 2006,
2009), from the lumbar spinal cord of adult male Sprague Dawley rats.
Briefly, the lumbosacral spinal cord was excised and longitudinally he-
misected, producing a horizontal slice with L4 and L5 dorsal roots at-
tached. One slice was obtained from each rat, mounted in the central
compartment of a three compartment chamber and continuously super-
fused (1 ml/min) with oxygenated (95% O2 plus 5% CO2) Krebs’ solu-
tion, as follows (in mM): 118 NaCl, 4.7 KCl, 1.2 MgSO4, 1.2 KH2PO4, 25
NaHCO3, 2.5 CaCl2, and 11 glucose, containing 0.1% bovine serum
albumin and 20 g/ml bacitracin to minimize protein degradation. The
dorsal roots were placed in the lateral compartments and immersed in
mineral oil to avoid dehydration.
Collection of superfusate samples. Before, during, and after chemical
stimulation, fractions of 8 ml of the superfusates were collected from the
central compartment in ice-chilled glass tubes to minimize IL-1 loss.
FKN was diluted in Krebs’ solution and superfused (200 ng/ml for 16
min) through naive dorsal horn slices. Three 8 ml fractions were col-
lected before stimulation (0–24 min) to measure basal levels of IL-1.
These values were then pooled and expressed as “basal.” Two fractions
were collected during FKN superfusion (24–40 min), and three frac-
tions were collected after FKN superfusion to assess recovery to basal
levels of IL-1 [recovery fraction (R) 1, 40–48 min; R2, 48–56 min;
R3, 56–64 min].
IL-1 quantification and data analysis. To quantify IL-1 content in
superfusates, 8 ml samples were desalted and concentrated using an
Ultrafree-15 10 K centrifugal device (Millipore). Retentates were lyoph-
ilized, reconstituted in 150 l of sample buffer (R&D Systems) and
assayed for IL-1 content by ELISA. Ninety-six-well colorimetric “sand-
wich” ELISA plates (IL-1/IL-1F2 Quantikine ELISA Kit, R&D Systems)
were used to determine IL-1 content. Rat recombinant IL-1 standards
(50 l of a 2000–15.6 pg/ml solution) and 50 l of unknown samples
were run in duplicate following the instructions of themanufacturer. The
optical density of each well was determined at a wavelength of 450 nm.
Samples were considered to be IL-1 positive when the signal was higher
than background signal (modified Krebs’ solution) and was within the
range of the standard curve.Data are expressed as the percentage of IL-1
content in the basal fractions.
Immunohistochemistry
At the completion of in vivo experiments, animals were under anesthesia,
transcardially perfused with a 0.9% saline solution followed by 4% para-
formaldehyde in 0.1 M phosphate buffer containing 1.5% picric acid. The
lumbar spinal cord was excised and post-fixed for 4 h in the perfusion
fixative. Spinal cord slices were fixed overnight in 4% paraformaldehyde
in 0.1 M phosphate buffer containing 1.5% picric acid. All tissues were
then cryoprotected in 20% sucrose in 0.1 M phosphate buffer (72 h at
4°C) and were frozen in O.C.T. embedding compound (VWR). Trans-
verse sections (20 m) were cut with a cryostat and thaw mounted onto
glass slides. For staining of the microglial cell population, phosphory-
lated p38 (p-p38)MAPK (rabbit anti-p-p38MAPK; 1:100; Cell Signaling
Technology) was visualized with extra avidin-FITC (1:500; Sigma) fol-
lowing signal amplification with ABC (Vector Laboratories) and biotinyl
tyramide (NEN Life Science Products) as previously described (Clark et
al., 2006, 2010, 2012). Sections were then incubated with a primary an-
tibody for Iba-1 (ionized calcium binding adapter molecule-1) followed
by a secondary antibody solution (goat anti-rabbit IgG-conjugated Alexa
Fluor 546, 1:1000; Invitrogen). Slides were coverslippedwith Vectashield
mounting medium (Vector Laboratories) and visualized under a Zeiss
LSM710 confocalmicroscope.Quantitative assessment of immunostain-
ing in spinal cord sections was performed by counting the number of
positive profiles within a fixed area of the dorsal horn (Clark et al., 2006,
2010, 2012). A box measuring 104 m2 was placed onto areas of the
lateral, central, and medial dorsal horn, and the number of profiles that
were positive for each marker were counted within this area. These mea-
surement protocols were performed on three spinal sections from each
animal per slice by an assessor blinded to treatment.
Statistical analysis
All values are given as the mean SEM. For the analysis of electrophys-
iological and release data, one-way repeated-measures (RM) ANOVA
followed by Tukey’s post hoc test was used. A Fisher’s exact test was used
to analyze the response incidence between groups for electrophysiologi-
cal data. For immunohistochemical data, one-way ANOVA followed by
Tukey’s post hoc test or Student’s t test was used as appropriate. A p level
of0.05 was set as the level of statistical significance.
Results
FKN induces facilitation of synaptic strength at the first
synapse in the nociceptive pathway
Is the activation ofmicroglia CX3CR1 sufficient to induce ampli-
fication of synaptic strength? We used the chemokine FKN to
specifically stimulate spinal microglia via the CX3CR1 receptor.
We first examined whether FKN was able to modulate microglia
reactivity in spinal cord slices using immunohistochemistry for
p-p38MAPK, amarker of rapidmicroglia reactivity (Svensson et
al., 2003; Clark et al., 2006). As expected, the number of Iba-1-
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positive microglial cells in spinal cord
slices remained unchanged following a 30
min application of FKN, compared with
time-matched control slices. However,
following FKN application, the number
of microglia exhibiting immunoreactivity
for p-p38MAPKwas enhanced compared
with control slices (Fig. 1A,B). In control
slices, 34  3% of Iba-1-positive micro-
glial cells exhibited p-p38 immunoreac-
tivity (Fig. 1A). This was significantly
enhanced (p  0.01, Student’s t test) fol-
lowing FKN application, with 63 6% of
microglia showing p-p38 immunoreac-
tivity (Fig. 1B).
We then examined whether FKN was
sufficient to modulate synaptic transmis-
sion between primary afferent C-fibers
and spinal lamina I neurons in vitro. Un-
der control conditions, C-fiber-evoked
EPSC amplitudes stayed stable at 106 
5% of baseline over a recording period of
40min (Fig. 1C). Bath application of FKN
increased synaptic strength at C-fiber syn-
apses in 18 of 31 neurons to 134  6%
of baseline (Fig. 1D). FKN-induced en-
hancement of synaptic strength is accom-
panied by a decrease in the PPR (Fig. 1E)
and an increase in the CV2 (Fig. 1F),
suggesting a potential presynaptic mecha-
nism of expression.
We concomitantly examined changes
in sEPSC in the presence of FKN. FKN
significantly increased the number of
sEPSCs recorded from lamina I neurons
to 157 21% of baseline (Fig. 1G; n 11;
p  0.01, one-way RM ANOVA), while
the amplitudes of the recorded sEPSCs re-
mained unchanged at 90 6%of baseline
(Fig. 1G; n  11; p  0.05, one-way RM
ANOVA). Under control conditions,
the number of sEPSCs remained stable
throughout the 40 min recording period,
reaching 88  6% and 95  4% of base-
line (n  7; p  0.05, one-way RM
ANOVA), respectively, at the time points
Figure 2. FKN-induced synaptic facilitation is transient in nature.A, FKN (200 ng/ml for 15min, black bar) induced a significant
facilitation of C-fiber-evoked EPSC in 6of 11neurons tested,which returned topretreatment values followingwashout (1254%
at 15min, 12612%at 30min,p0.001; 1079%at 50min,p0.05; one-wayRMANOVA). Filled circles represent neurons
showing facilitation; open cycles represent neurons showing no change after FKN application. B–D, FKN significantly modified
sEPSCs (B), PPR (C), and CV2 (D) during application, with all measures returning to pretreatment values following washout.
*p 0.05, one-way RM ANOVA. E, In identified projection neurons, FKN (200 ng/ml for 15 min, black bar) induced a significant
facilitation of C-fiber-evoked EPSCs in 7 of 10 neurons tested, which returned to pretreatment values following washout (124
4
4% at 15min, 131 9% at 20min, p 0.001; 107 3% at
50 min, p 0.05; one-way RM ANOVA). Filled circles repre-
sent neurons showing facilitation; open circles represent
neurons showing no change after FKN application. F–H, FKN-
modified sEPSCs (F), PPR (G), and CV2 (H) during applica-
tion, with all measures returning to pretreatment values
following washout. *p  0.05, **p  0.01, one-way RM
ANOVA. I, Iba-1 (red) and p-p38 MAPK (green; colocalization
with Iba-1, yellow) immunoreactivity in the dorsal horn of spi-
nal cord slices following 15 min incubation with FKN, 15 min
FKN followed by a 30min washout period, and time-matched
control slices for each condition. Scale bars, 50m. J, Quanti-
fication of the percentage of Iba-1-positivemicroglial cells ex-
pressing immunoreactivity for p-p38 MAPK in the dorsal horn
of spinal cord slices.
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equivalent to 10 and 20 min after FKN application. sEPSC am-
plitudes also remained stable under control conditions, reaching
96 3% and 96 2% of baseline (n 7; p 0.05, one-way RM
ANOVA) at the time points equivalent to 10 and 20 min after
FKN application. We then recorded mEPSCs in the presence of
TTX in separate neurons. FKN significantly increased the num-
ber of mEPSCs to 173 22% of baseline, while the amplitude of
mEPSCs remained stable at 92 4% of baseline (Fig. 1H).
We then examined whether FKN was sufficient to modulate
synaptic transmission between primary afferent A-fibers and
spinal lamina I neurons. Under control conditions, A-fiber-
evoked EPSC amplitudes stayed stable at 88  8% of baseline
over a recording period of 40 min (Fig. 1I). In 12 neurons tested,
bath application of FKN did not significantly modify A-fiber-
evoked EPSC amplitudes compared with control cells, reaching
89  7% of baseline (Fig. 1J). These data suggest that FKN-
induced changes in synaptic strength are input specific, occurring
between primary afferent C-fibers and lamina I neurons, but not
between primary afferent A-fibers and lamina I neurons.
We next investigated the duration of FKN-induced changes to
synaptic strength to determine whether this effect was LTP or a
short-term facilitation. FKN induced a significant increase in
synaptic strength at C-fiber synapses in 6 of 11 neurons to 125
4% of baseline at 15 min following FKN application (Fig. 2A).
Following FKN washout, synaptic strength remained signifi-
cantly enhanced at 30 min (126 12% of baseline; 15 min after
FKN washout), but returned to baseline values thereafter (108
10% and 98  2% of baseline, respectively, at 40 and 50 min).
Indeed, FKN induced significant changes in sEPSCs (Fig. 2B),
PPR (Fig. 2C), and CV2 (Fig. 2D) during application, with all
parameters returning to control values following FKN washout.
We further examined whether projection neurons also re-
sponded to FKN in a similar manner to unidentified neurons.
Following injection of the retrograde tracer DiI into the PAG
projection neurons can be identified by DiI labeling in the slice.
Indeed, FKN induced a significant increase in synaptic strength at
C-fiber synapses in 7 of 10 identified projection neurons to 124
5% of baseline at 15 min following FKN application (Fig. 2E).
Following FKN washout, synaptic strength remained signifi-
cantly enhanced at 20 min (131  9% of baseline, 5 min after
FKN washout), but returned to baseline values thereafter (109
16%, 113 5%, and 107 3% of baseline, respectively, at 30, 40
and 50 min). FKN-induced changes in sEPSCs (Fig. 2F), PPR
(Fig. 2G), and CV2 (Fig. 2H) during application, with all pa-
rameters returning to control values following FKNwashout.We
further investigated whether the return of synaptic strength to
baseline values following the washout of FKN was paralleled by
observable changes in microglia reactivity. Similarly to a 30 min
application of FKN (Fig. 1A,B), incubation of spinal cord slices
with FKN for 15 min induced a significant increase in the per-
4
Figure 3. FKN-induced synaptic facilitation in vivo is CX3CR1 dependent. The area of the
C-fiber-evoked field potential (percentage of control) is plotted against time (in minutes). A,
Schematic drawing of the recording setup for in vivo experiments. B, Application of FKN (200
ng/ml for 240 min, black bar) to the spinal cord induced a facilitation of C-fiber-evoked field
potentials in all rats tested, which returned to pretreatment values following washout (223
28% at 240 min, p  0.001; 111  7% at 370 min, p  0.05; one-way RM ANOVA). C,
FKN-induced facilitation was completely prevented by spinal application of a CX3CR1 neutral-
izing antibody (rabbit anti-CX3CR1; 60 g/ml; 1 h before FKN application, open bar; 110
12% at 180 min, p 0.05, one-way RM ANOVA). D, FKN-induced facilitation was evident
following spinal application of control IgG (rabbit IgG; 60g/ml; 1 h before FKN application,
open bar; 217 19% at 180 min, p 0.05, one-way RM ANOVA).
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Figure4. FKN inducedmicroglia reactivity in vivo.A, Iba-1 (red) andp-p38MAPK (green; colocalizationwith Iba-1, yellow) immunoreactivity in the dorsal horn of the spinal cord following in vivo
experiments. Spinal cordswere excisedunder the following conditions: laminectomyonly, IgG alone, IgGplus FKN for 180min, IgGplus FKNpluswashout for 60min, anti-CX3CR1alone, anti-CX3CR1
plus FKN for 180 min, and anti-CX3CR1 plus FKN plus washout. Scale bars: low-magnification panels, 200m; higher-magnification panels, 100m. n 4 rats/group. B, Quantification of the
percentage of Iba-1-positive microglial cells expressing immunoreactivity for p-p38 MAPK in the dorsal horn of the spinal cord.
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Figure5. The effects of FKN aremediated bymicroglial CX3CR1.A–D, In the presence of anti-FKN (goat anti-FKN; 2g/ml for 1 h preincubation then 1g/ml for duration of the recording, open
bar), FKN (black bar) does not modify C-fiber-evoked EPSCs (A), sEPSCs (B), PPR (C), or CV2 (D) in any neuron tested. p 0.05, one-way RM ANOVA. E, In the presence of control IgG (goat IgG; 2
g/ml for 1 h preincubation then 1 g/ml for the duration of the recording, open bar), FKN (black bar) induced a significant facilitation of C-fiber-evoked EPSC (Figure legend continues.)
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centage of Iba-1-positive microglia-expressing immunoreactiv-
ity for p-p38MAPK, compared with time-matched control slices
(Fig. 2 I, J). In contrast, in spinal cord slices that received a 15min
application of FKN followed by a 30minwashout period the level
of p-p38 MAPK immunoreactivity was comparable to time-
matched control slices (Fig. 2 I, J). Thus, these data suggest that
synaptic facilitation induced by FKN is mirrored by detectable
changes in microglia reactivity state.
FKN modulation of synaptic transmission was further exam-
ined in vivo (Fig. 3). Spinal application of FKN induced an en-
hancement of C-fiber-evoked field potentials in all rats tested,
4
(Figure legend continued.) amplitude in five of eight neurons tested [124 4% at 30 min,
p 0.01, one-way ANOVA; p 0.05 compared with anti-FKN cells (A), Fisher’s exact test].
Filled circles represent neurons showing facilitation; open circles represent neurons showing no
change after FKN application. F, FKN application following IgG preincubation is associatedwith
an increase in the number of sEPSCs [149 13% at 10 min, 147 16% at 20 min after FKN
(n 8)] comparedwith pretreatment values (**p 0.01, one-way RMANOVA).G,H, Follow-
ing IgG application, facilitation of C-fiber-evoked EPSCs by FKN is associated with a decrease in
the PPR (G) and an increase in the CV2 value (H) compared with pretreatment values (*p
0.05, **p 0.01, one-way RM ANOVA).
Figure 6. FKN-induced facilitation is inhibited byminocycline.A, Incubation of slices withminocycline (100M for 90min preincubation then 20M for the duration of the recording, open bar)
completely prevents the effects of FKN (black bar) on C-fiber-evoked EPSCs. p 0.05, one-way RM ANOVA. B, In six neurons tested, C-fiber-evoked EPSC amplitude stays constant in the presence
ofminocycline alone (open bar, p 0.05, one-way RMANOVA). C–E, In the presence ofminocycline FKN-induced changes in PPR (C), CV2 (D), and sEPSCs (E) are prevented in all neurons tested.
p 0.05, one-way RM ANOVA.
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reaching 223 28%of baseline (Fig. 3B). This enhanced synaptic
strength in vivo returned to pretreatment values following wash-
out of FKN (Fig. 3B) and was completely prevented by spinal
pretreatment with a CX3CR1 neutralizing antibody (Fig. 3C). In
contrast, FKN still induced a significant enhancement of synaptic
strength following spinal pretreatment with a control IgG (Fig.
3D).We next used immunohistochemistry to determine whether
FKN-induced synaptic facilitation in vivo was a result of quanti-
fiable changes in microglial reactivity. As predicted, the number
of Iba-1-positive microglial cells remained unchanged under any
condition (Fig. 4). Critically, FKN application induced a signifi-
cant increase in the percentage of dorsal horn microglia exhibit-
ing immunoreactivity for p-p38 MAPK. In the presence of IgG,
the percentage of microglia expressing p-p38 was significantly
enhanced 180 min following FKN application, compared with
IgG alone, and was comparable to IgG control levels 60 min
following the washout of FKN (Fig. 4A,B). Conversely, when
administered in the presence of anti-CX3CR1, FKN application
did not lead to any changes in p-p38 levels compared with anti-
CX3CR1 alone (Fig. 4A,B). Thus, FKN-induced synaptic facili-
Figure 7. Release of IL-1 is critical for FKN-induced facilitation.A, Superfusion of FKN (200 ng/ml for 16min) resulted in a significant release of IL-1 from the dorsal horn (n 13 slices; black
columns; ***p 0.001 comparedwith basal values, one-wayANOVA).Minocycline (MIN) incubated before and during FKN superfusion (100M; 24min in total) inhibits FKN-evoked IL-1 release
(n 12 slices; gray columns; p 0.05 compared with basal values, one-way ANOVA). Basal release: FKN 21.48 1.69 pg/8ml fraction. FKN	MIN 23.06 0.79 pg/8ml fraction. B–E, In
the presence of IL-1ra (40 ng/ml for 20min preincubation and the duration of the recording, open bar), FKN-induced facilitation of C-fiber-evoked EPSCs (B) and changes in PPR (C; black circles, left
hand axis) and CV2 (C; white squares, right hand axis) were prevented in all neurons tested (B, C; p 0.05, one-way RMANOVA), while a decrease in the number of sEPSCs occurred (E; 81 7%
at 20 min after FKN [n 8]; *p 0.05, one-way RM ANOVA). C-fiber-evoked EPSC amplitude stays constant in the presence of IL-1ra alone (D; open bar, p 0.05, one-way RM ANOVA).
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tation in vivo is mirrored by detectable changes in microglia
reactivity. These data suggest that FKN induces a facilitation of
synaptic transmission at C-fiber synapses in vitro and in vivo that
is dependent on CX3CR1 receptor signaling.
Release of microglial interleukin-1 initiates
FKN-induced facilitation
We next examined the microglial mechanisms by which FKN
induces the facilitation of synaptic strength. Preincubation of
spinal cord slices with an anti-FKN to specifically inhibit micro-
glia CX3CR1 signaling completely prevented FKN-induced
changes in synaptic strength at C-fiber synapses (Fig. 5A) and
sEPSCs (Fig. 5B) in all neurons tested. FKN-induced changes in
PPR (Fig. 5C) and CV2 (Fig. 5D) were also prevented in the
presence of anti-FKN. In contrast, following preincubation of
spinal cord slices with a control IgG, FKN increased synaptic
strength at C-fiber synapses in five of eight neurons to 124 4%
of baseline (Fig. 5E). In addition, significant FKN-induced
changes in sEPSCs (Fig. 5F), PPR (Fig. 5G), and CV2 (Fig. 5H)
occurred in the presence of IgG. Likewise,minocycline prevented
Figure8. FKN-induced facilitation is independent of TNF signaling.A, In thepresence of sTNFR1 (0.5g/ml for 20minpreincubation and theduration of the recording, openbar), FKN (black bar)
induceda significant facilitationof C-fiber-evokedEPSCamplitude in6of 11neurons tested (1267%at30min,p0.01, one-wayANOVA;p0.05 comparedwith control cells [B], Fisher’s exact
test). Filled circles represent neurons showing facilitation; open circles represent neurons showing no change after FKN application.B, In six neurons tested, the C-fiber-evoked EPSC amplitude stays
constant in the presence of sTNF R1 alone (open bar, p 0.05, one-way RMANOVA). C,D, Following sTNF R1, facilitation of C-fiber-evoked EPSCs by FKN is associatedwith a decrease in the PPR (C)
and an increase in the CV2 value (D) compared with pretreatment values (*p 0.05, one-way RM ANOVA). E, FKN application following sTNF R1 preincubation is associated with an increase in
the number of sEPSCs [121 3% at 10 min, 131 7% at 20 min after FKN (n 10)] compared with pretreatment values (***p 0.001, one-way RM ANOVA).
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the effects of FKN on both C-fiber-evoked EPSCs (Fig. 6A) and
sEPSCs (Fig. 6E) in all neurons tested. FKN-induced changes in
PPR (Fig. 6C) and CV2 (Fig. 6C,D) were also prevented. The
presence of minocycline alone did not modify C-fiber-evoked
EPSCs (Fig. 6B). Thus, the effect of FKNon synaptic transmission
is mediated via microglial CX3CR1 receptors in the dorsal horn
of the spinal cord.
Release of a soluble microglial mediator likely arbitrates the
changes in synaptic strength observed. We investigated the con-
tribution of two classic proinflammatory cytokines, IL-1 and
TNF, since these cytokines are able to modulate synaptic trans-
mission (Kawasaki et al., 2008; Gruber-Schoffnegger et al., 2013).
We first examined the release of IL-1 in response to FKN using
the spinal dorsal horn preparation with dorsal roots attached.
Superfusion of dorsal horn slices with FKN resulted in a signifi-
cant release of IL-1, reaching 155  18% of basal values (Fig.
7A). In addition, FKN-induced release of IL-1 was completely
prevented when dorsal horn slices were incubated with minocy-
cline (Fig. 7A), suggesting that microglia are a likely source of the
secreted IL-1. We next studied whether IL-1 release is neces-
sary for FKN-induced facilitation. Indeed, inhibition of IL-1
signaling using IL-1ra was able to completely prevent FKN-
induced changes in C-fiber-evoked EPSCs (Fig. 7B), PPR, and
CV2 (Fig. 7C). The presence of IL-1ra alone did not modify
C-fiber-evoked EPSCs (Fig. 7D). Interestingly, in the presence of
IL-1ra FKN resulted in a small but significant decrease in the
number of sEPSCs (Fig. 7E).
In contrast, the inhibition of TNF signaling using sTNF R1 did
not modify FKN-induced facilitation (Fig. 8A). In the presence of
sTNFR1,FKNincreased synaptic strengthatC-fiber synapses in6of
11 neurons to 126 7%of baseline, whereas sTNFR1 alone did not
modify C-fiber-evoked EPSCs (Fig. 8B). In addition, significant
FKN-induced changes in PPR (Fig. 8C), CV2 (Fig. 8D), and sEPSCs
(Fig. 8E) occurred following sTNF R1. These data suggest that FKN-
induced facilitation requires IL-1 signaling, while the role of TNF sig-
naling appears limited under our experimental conditions.
NMDA-dependent postsynaptic mechanismsmediate
FKN-induced facilitation
While changes in PPR, CV2, and sEPSC frequency suggest a
presynaptic expression of FKN-induced synaptic facilitation, we
next investigated whether postsynaptic mechanisms contribute
to its induction. First, we examined the role of intracellular Ca2	,
which is critical for activity-dependent LTP (Ikeda et al., 2003;
Ikeda et al., 2006). Indeed, the inclusion of the Ca2	 chelator
BAPTA in the pipette solution completely prevented increased
synaptic strength at C-fiber synapses following FKN application
in all neurons tested (Fig. 9A). No changes in PPR or CV2 were
observed (Fig. 9B). Interestingly, an increase in the number of
sEPSCs was still apparent in the absence of postsynaptic Ca2	
(Fig. 9C), suggesting that evoked measures of synaptic strength
can be dissociated from changes in spontaneous events.
Second, we examined the contribution of NMDA receptors,
the activation of which leads to a large increase in intracellular
Ca2	 and can be modulated by IL-1 (Gruber-Schoffnegger et
al., 2013). MK801 applied internally at a concentration of 1 mM
used here effectively inhibits NMDA currents in the neuron to
which it is applied, with no spillover into the extracellular envi-
ronment, as neighboring neurons recorded simultaneously dem-
onstrated normal NMDA-mediated currents (Bender et al.,
2006). The blockade of postsynaptic NMDA receptors by the
addition of MK801 to the pipette solution completely prevented
FKN-induced facilitation in all neurons tested (Fig. 9D). FKN-
induced changes in PPR and CV2 were also prevented (Fig. 9E).
Figure 9. FKN-induced facilitation requires postsynaptic Ca 2	 signaling and NMDA receptors. A–C, Inclusion of BAPTA (20 mM, open bar) in the pipette solution to block Ca 2	 signaling in the
postsynaptic neuron completely prevented FKN-induced changes to C-fiber-evoked EPSC (A), PPR (B; black circles, left hand axis) and CV2 (B; white squares, right hand axis), in all neurons tested
(A,B;p0.05, one-wayRMANOVA). However, a significant increase in thenumber of sEPSCs still occurred [C; 13614%at 10min after FKNapplication (n8); *p0.05, one-wayRMANOVA].
D–F, The addition ofMK801 (1mM, openbar) to thepipette solution in order to specifically inhibit postsynaptic NMDA receptors prevents the effects of FKNonC-fiber-evoked EPSCs (D), PPR (E; black
circles, left hand axis), and CV2 (E; white squares, right hand axis) in all neurons tested (D, E; p 0.05, one-way RMANOVA). However, a significant increase in the number of sEPSCs still occurred
[F; 132 12% at 10 min after FKN (n 8); *p 0.05, one-way RM ANOVA].
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Similar to BAPTA experiments, an increase in the number of
sEPSCswas apparent in the presence of postsynapticMK801 (Fig.
9F). These data suggest that the activation of postsynaptic
NMDA receptors and subsequent rises in intracellular Ca2	 lev-
els are necessary for FKN-induced synaptic facilitation, and that
evoked measures of synaptic strength can be dissociated from
changes in spontaneous events.
In the hippocampus, FKN facilitates NMDA receptor func-
tion via D-serine (Scianni et al., 2013). We therefore deter-
mined whether D-serine was required for FKN-induced
synaptic facilitation at C-fiber synapses. Degradation of en-
dogenous D-serine by the enzyme D-AAO did not modify
FKN-induced facilitation (Fig. 10A). Following the incubation
of slices with D-AAO, FKN increased synaptic strength at
C-fiber synapses in five of nine neurons tested to 138 5% of
baseline, whereas D-AAO alone did not modify C-fiber-
evoked EPSCs (Fig. 10B). In addition, significant FKN-
induced changes in PPR (Fig. 10C), CV2 (Fig. 10D), and
sEPSCs (Fig. 10E) occurred following D-AAO application.
These data suggest that postsynaptic Ca2	 and NMDA recep-
Figure 10. D-Serine is not required for FKN-induced facilitation.A, In the presence of D-AAO (0.2 U/ml for 1 h preincubation and the duration of the recording, open bar) to degrade D-serine, FKN
(black bar) induced a significant facilitation of C-fiber-evoked EPSC amplitude in five of nine neurons tested [138 5%at 30min, p 0.001, one-wayANOVA; p 0.05 comparedwith control cells
(B), Fisher’s exact test]. Filled circles represent neurons showing facilitation; open circles represent neurons showing no change after FKN application. B, In six neurons tested, C-fiber-evoked EPSC
amplitude stays constant in the presence of D-AAO alone (open bar, p 0.05, one-way RMANOVA). C,D, FollowingD-AAO application, facilitation of C-fiber-evoked EPSCs by FKN is associatedwith
a decrease in the PPR (C) and an increase in the CV2 value (D) compared with pretreatment values (***p 0.001, **p 0.01, one-way RM ANOVA). E, Application of FKN following D-AAO is
associated with an increase in the number of sEPSCs [153 11% at 10 min, 188 27% at 20 min after FKN application (n 9)] compared with pretreatment values (**p 0.01, *p 0.05,
one-way RM ANOVA).
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tors are critical for the induction of synaptic facilitation by
FKN; however, D-serine is not required.
Eicosanoids act as possible retrograde messengers during
FKN-induced facilitation
The role of postsynaptic Ca2	 and NMDA receptors for the in-
duction of synaptic facilitation, in combination with changes in
parameters that suggest a presynaptic expression, lead us to hy-
pothesize that a retrograde messenger mediates FKN-induced
facilitation. A number of candidates have been proposed as ret-
rograde messengers that modulate synaptic transmission. First,
we examined the role of nitric oxide (NO), which is critical for
activity-dependent LTP at C-fiber synapses (Ikeda et al., 2006).
Indeed, the incubation of slices with a membrane-impermeable
nitric oxide scavenger (cPTIO) to remove extracellular NO pre-
vented FKN-induced changes in C-fiber-evoked EPSCs (Fig.
11A), PPR/CV2 (Fig. 11B), and sEPSCs (Fig. 11C) in all neurons
tested. A number of cell types within the spinal cord are potential
sources of NO, including glial cells, which express inducible NO
synthase (iNOS). In the presence of the specific iNOS inhibitor
1400W, FKN no longer modified C-fiber-evoked EPSCs (Fig.
11D), PPR/CV2 (Fig. 11E), or sEPSCs (Fig. 11F) in any neurons
tested.Neither cPTIOnor 1400WalonemodifiedC-fiber-evoked
EPSC (Fig. 11C,F). From these data, we conclude that the source
of NO is unlikely to be the postsynaptic neuron, but is likely to be
spinal glial cells, and therefore does not act as a retrograde mes-
senger under our experimental conditions.
We next examined the contribution of arachidonic acid (AA),
which is synthesizedwithin neurons followingNMDAandCa2	-
dependent activation of phospholipase A2 (PLA2; Dumuis et al.,
1988; Sanfeliu et al., 1990; Taylor et al., 2008), to FKN-induced
synaptic facilitation. AA and its derivatives the prostaglandins
(PGs) may act as retrograde messengers in the hippocampus
(Williams et al., 1989; Sang et al., 2005). We therefore incubated
slices with the PLA2 inhibitor AACOCF3 to prevent the forma-
tion of AA, and therefore PGs. AACOCF3 completely prevented
FKN-induced changes in C-fiber-evoked EPSCs (Fig. 12A), PPR/
CV2 (Fig. 12B), and sEPSCs (Fig. 12C) in all neurons tested.
AACOCF3 alone did not modify C-fiber-evoked EPSCs (Fig.
12D). Importantly, in the presence of 0.05% DMSO (the vehicle
control for AACOCF3) FKN increased synaptic strength at
C-fiber synapses in five of nine neurons tested to 129  4%
Figure11. The facilitatory effects of FKN aremediated byNO.A–C, In the presence of cPTIO (30M for 30min preincubation and the duration of the recording, openbar) FKN-induced facilitation
of C-fiber-evoked EPSC (A), changes in PPR (B; black circles, left hand axis) and CV2 (B; white squares, right hand axis), and sEPSCs (C) was completely prevented in all neurons tested ( p 0.05,
one-way RMANOVA).D–F, Following incubation of slices with 1400W (3M for 30min preincubation and the duration of the recording, open bar), FKN does notmodify C-fiber-evoked EPSCs (D),
PPR (E; black circles, left hand axis), CV2 (E; white squares, right hand axis), or sEPSCs (F) in any of the neurons tested ( p 0.05, one-way RMANOVA).G,H, C-fiber-evoked EPSC amplitude stays
constant in the presence of cPTIO alone (G; open bar) or 1400W alone (H; open bar). p 0.05, one-way RM ANOVA.
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Figure 12. The facilitatory effects of FKN aremediated by PLA2.A–C, Inhibition of PLA2 (AACOCF3; 10M for 20min preincubation then for the duration of the recording, open bar) prevents the
effects of FKN (black bar) on C-fiber-evoked EPSCs (A), PPR (B; black circles, left hand axis), CV2 (B; white squares, right hand axis), and sEPSCs (C) in all neurons tested ( p 0.05, one-way RM
ANOVA). D, C-fiber-evoked EPSC amplitude stays constant in the presence of AACOCF3 alone (open bar, p 0.05, one-way RM ANOVA). E, In the presence of DMSO (0.05% final concentration; for
20 min preincubation then for the duration of the recording, open bar), FKN (black bar) induced a significant facilitation of C-fiber-evoked EPSC amplitude in five of (Figure legend continues.)
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of baseline (Fig. 12E). In addition, significant FKN-induced
changes in sEPSCs (Fig. 12F), PPR (Fig. 12G), and CV2 (Fig.
12H) occurred following DMSO application. These data suggest
that the effect of FKN on synaptic transmission is mediated via
the release of AA/PGs, resulting in enhanced neurotransmitter
release from the presynaptic neuron.
These data suggest that NO originating from spinal glia is
critical for FKN-induced facilitation; however, it is unlikely that
NO is acting as a retrograde messenger under our experimental
condition. In contrast, AA or one of its derivatives may be a
critical retrograde signal for FKN-induced facilitation.
Discussion
We demonstrate that highly selective activation of microglia is
sufficient in itself to enhance synaptic strength. Specifically, the
stimulation of microglial CX3CR1 receptors using FKN is suffi-
cient to facilitate synaptic strength at the first synapse in the no-
ciceptive pathway. The effect of FKN is rapid, with modifications
in synaptic strength observed within minutes of application or
washout. Thus, FKN quickly and reversibly enhances synaptic
strength in a feedforward manner. This finding is unexpected; it
is usually assumed that short-term synaptic plasticity involves
essentially presynaptic and postsynaptic neuronal elements. Classic
indicators of neuronalmechanisms are requirements for postsynap-
tic Ca2	 and NMDA receptor activation (Bliss and Collingridge,
1993; Malenka and Bear, 2004), both of which are necessary for
FKN-induced facilitation. In contrast, glial activation is consid-
ered to be supportive only. Although glial cell activity is necessary
for plasticity, it has been suggested recently that the classic mech-
anisms by which glial cells modulate neurotransmission in the
adult be reconsidered (Agulhon et al., 2010; Sun et al., 2013). The
present data demonstrate that microglia activation is sufficient
for rapidly induced and reversible synaptic modulation.
We propose a flow of signaling cascades, as illustrated in Fig-
ure 13A, resulting in amicroglia-driven synaptic facilitation. Spe-
cifically, the activation of microglial CX3CR1 receptors in the
dorsal horn induces the release of microglial mediators such as
IL-1, which act tomodulate postsynapticNMDAreceptor func-
tion. A rise in intracellular Ca2	 levels in the postsynaptic neuron
stimulates the synthesis of AA via Ca2	-dependent PLA2. AA/
PGs feed back onto microglial cells, where they induce iNOS
activity resulting in NO production, which enhances presynaptic
neurotransmitter release. This signaling cascade for synaptic
facilitation contrasts traditional mechanisms required for
activity-dependent LTP at C-fiber synapses (Sandku¨hler, 2009;
Gruber-Schoffnegger et al., 2013; summarized in Fig. 13B).
FKN-induced facilitation of synaptic strength comprises post-
synaptic induction and presynaptic expression. It remains un-
clear why postsynaptic NMDA receptors and Ca2	 signaling give
rise to short-term plasticity following FKN application, while in-
ducing LTP or LTD under other experimental conditions. The
precise spatiotemporal pattern of postsynaptic calcium may de-
termine which intracellular signaling pathways are activated and
therefore how synaptic strength is modulated (Malenka et al.,
1992; Sheng and Kim, 2002). Interestingly, in the hippocampus,
FKN/CX3CR1 signaling depresses excitatory synaptic transmission
via NMDA-independent postsynaptic mechanisms (Ragozzino et
al., 2006) and impairs LTP (Maggi et al., 2009). This is in line with
the divergent neuroprotective effects of CX3CR1-expressing mi-
croglia in the brain (Cardona et al., 2006) versus the pronocice-
ptive effects of CX3CR1-expressing microglia in the spinal cord
(Milligan et al., 2004, 2005; Clark et al., 2007, 2012; Zhuang et al.,
2007), which are likely mediated via distinct intracellular signal-
ing pathways. Indeed, FKN/CX3CR1 signaling is neuroprotective
via ERK and phosphoinositide 3 kinase pathways (Limatola et al.,
2005) and inhibition of cytokine release (Cardona et al., 2006). In
contrast, CX3CR1 deficiency prevents the development of
chronic pain (Staniland et al., 2010). The pronociceptive effects
of FKN/CX3CR1 signaling are mediated by p38 MAPK and the
release of cytokines (Milligan et al., 2005; Clark et al., 2007;
Zhuang et al., 2007). Interestingly, in the hippocampus, FKN
facilitates NMDA receptor currents via D-serine (Scianni et al.,
2013). We found no role for D-serine in FKN-induced synaptic
facilitation, further highlighting the divergent mechanisms by
which FKN modulates excitatory transmission and the distinct
phenotypes of glial cells in different CNS regions (Hanisch and
Kettenmann, 2007). Indeed, glia cell contribution to synaptic
transmission differs greatly between the brain and spinal cord
(Ben Achour and Pascual, 2010; Zhong et al., 2010; Gruber-
Schoffnegger et al., 2013).
Here we have delineated mechanisms by which specific micro-
glial signaling pathways can dynamically modulate synaptic
strength. CX3CR1 receptor activation results in the release of IL-1
in the dorsal horn, which is critical for FKN-induced facilitation.
Interestingly, despite IL-1 directly enhancing NMDA receptor
phosphorylation in the dorsal horn (Gruber-Schoffnegger et
al., 2013), its effects on neuronal excitability may occur via an
indirect glial mechanism (Constandil et al., 2009; Gruber-
Schoffnegger et al., 2013; Liu et al., 2013), potentially by inducing
the release of a cocktail of proinflammatory cytokines (Gruber-
Schoffnegger et al., 2013). An essential need for glial cell activity
in cytokine-mediated neuronal plasticity is in line with the
microglia-arbitrated facilitation reported here. Exogenous levels
of IL-1 applied previously are much higher than the endoge-
nous levelsmeasured here following FKNapplication, potentially
accounting for the LTP reported following exogenous IL-1 appli-
cation (Gruber-Schoffnegger et al., 2013)versus the short-termplas-
ticity observed following FKN application. It is currently unclear
how the extracellular cytokine composition following FKNappli-
cation, which includes IL-1, relates to that after exogenous
IL-1 application. In contrast, we found no evidence for TNFR1
signaling during FKN-induced facilitation under our experimen-
tal conditions; however, the contribution of TNFR2 remains un-
known. Glia-derived TNF has been proposed to enhance spinal
excitatory synaptic transmission under other experimental con-
ditions (Gruber-Schoffnegger et al., 2013; Berta et al., 2014). The
contributions of IL-1 andTNF to FKN-induced facilitationmay
be due to the extensive phenotypic diversity of microglia (Hanisch
andKettenmann,2007).Thus,differentmicroglia-activating stimuli
may result indifferentmixtures of gliotransmitters and, therefore, in
diverse effects on synaptic transmission.
The data presented here indicate that FKN-induced release of
IL-1 from microglia modulates postsynaptic NMDA receptor
function, resulting in increased intracellular Ca2	 levels and syn-
thesis of AA/PGs, via PLA2. Both AA and PGs act as retrograde
4
(Figure legend continued.) nine neurons tested [125 4% at 30 min, p 0.01, one-way
ANOVA; p 0.05 comparedwith AACOCF3 cells (A), Fisher’s exact test]. Filled circles represent
neurons showing facilitation; open circles represent neurons showing no change after FKN
application. F, FKN application following DMSO preincubation is associated with an increase in
the number of sEPSCs [132 7%at 10min, 127 7%at 20min after FKN (n 9)] compared
with pretreatment values (**p 0.01, one-way RM ANOVA). G, H, Following DMSO applica-
tion, facilitation of C-fiber-evoked EPSCs by FKN is associatedwith a decrease in the PPR (G) and
an increase in the CV2 value (H) comparedwithpretreatment values (*p0.05, **p0.01,
one-way RM ANOVA).
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messengers in the hippocampus (Wil-
liams et al., 1989; Sang et al., 2005). Sev-
eral lines of evidence suggest that the
source of AA/PGs in the dorsal horn is the
postsynaptic neuron, rather than glial
cells. First, in the naive spinal cord, PLA2
expression is neuronal (Ong et al., 1999;
Kim et al., 2008), not glial (Kim et al.,
2008), with microglial expression occur-
ring only following injury (Liu et al.,
2006). Second, NMDA receptor activa-
tion induces Ca2	-dependent, PLA2-
dependent release of both AA and PGs
from neurons, but not from astrocytes
(Taylor et al., 2008). PGs may act to en-
hance synaptic transmission by acting di-
rectly on the presynaptic neuron (Minami
et al., 1999); however, we suggest that fol-
lowing FKN application PGs induce the
expression of iNOS in glial cells; iNOS ex-
pression is observed in spinal glial cells,
but not in spinal neurons (Dauch et al.,
2012). Thus, we suggest that during FKN-
induced facilitation NO acts as a glial sig-
naling factor, not a retrograde messenger.
This hypothesis is supported by known in-
teractions between iNOS and PGs (Minami
et al., 1995;Gu¨hring et al., 2000). Therefore,
PG-induced releaseofNOfromgliamayact
tomodulatepresynaptic activity, as intracel-
lular targets ofNOwithin the primary affer-
ent terminal are critical for spinal LTP (Luo
et al., 2012). Each individual component of
the signaling cascades delineated here is
known to modulate nociceptive transmis-
sion in vivo. PLA2 critically contributes to
inflammatory pain states, with neuronal PG
release regulated by IL-1 and NMDA re-
ceptor activation (Malmberg and Yaksh,
1992; Samad et al., 2001; Svensson and
Yaksh, 2002; Lucas et al., 2005).
A role for neuron–microglia commu-
nication in chronic pain states is now well
established (Clark andMalcangio, 2012; Ji
et al., 2013; Xanthos and Sandku¨hler,
2014).Microglialmediators canmodulate
synaptic transmission (Coull et al., 2005;
Gruber-Schoffnegger et al., 2013; Berta
et al., 2014); however, the mechanisms
remain tobe fully determined.Herewepro-
videdirect evidence that amicroglia-specific
receptor modulates synaptic transmission
in the dorsal horn, providing mechanistic
insight, which has been lacking until
now. The microglial chemokine receptor
CX3CR1 is a promising therapeutic target
for chronic pain treatment (Clark et al.,
2011; Clark and Malcangio, 2014). Intra-
thecal FKN induces pain hypersensitivity
in naive rodents (Milligan et al., 2004,
2005; Clark et al., 2007; Zhuang et al.,
2007) via stimulation of a CX3CR1-
enhanced response state in microglia
Figure 13. Schematic of the proposed mechanism of FKN-induced synaptic facilitation. A, We propose a novel mechanism by
which FKN induces synaptic facilitation. Activation ofmicroglial CX3CR1 receptors (1) results in the release of IL-1 (2), which acts
tomodulate postsynaptic NMDA receptors (3). Increased intracellular Ca 2	 in the postsynaptic neuron stimulates synthesis of AA
via PLA2 (4). AA/PGs feed back onto themicroglial cells, where they induce iNOS activity and subsequent NO production (5), which
modulates presynaptic neurotransmitter release. AA/PGs may also act directly on the presynaptic neuron. MPL, Membrane phos-
pholipids. B, The proposed mechanism of FKN-induced facilitation is in contrast with the traditional mechanisms of activity-
dependent LTP. At synapses between C-fibers and lamina I neurons, HFS/LFS triggers the release of the excitatory
neurotransmitters glutamate and substance P, leading to depolarization of the postsynaptic cell. Potentiation of synaptic strength
requires activation of T-type VDCCs (leading to Ca 2	 influx), NK1 receptors, release of Ca 2	 from intracellular stores, and activa-
tion of intracellular proteases, including PLC, PKC, and CaMKII, which lead to the phosphorylation of glutamate receptors. Several
microglial signaling mechanisms may also contribute, including the P2X7 receptor and intracellular signaling via p38 MAPK and Src.
AMPAR, AMPA receptor; CaMKII, Ca 2	-calmodulin dependent kinase II; HFS, high-frequency stimulation; IP3R, inositol 1,4,5-
trisphosphate receptor;LFS, low-frequencystimulation;NK1R,neurokinin receptor1;NMDAR,NMDAreceptor;nNOS,neuronalnitricoxide
synthase; PKC, protein kinase C; PLC, phospholipase C; RyR, ryanodine receptor; VDCC, voltage-dependent Ca2	 channel.
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(Clark et al., 2007) and the subsequent release of proinflamma-
tory mediators, including IL-1 and NO (Milligan et al., 2005).
In the dorsal horn, neuronal transmembrane FKN is proteolyti-
cally cleaved by CatS into soluble FKN that is pronociceptive
(Clark et al., 2007). Thus, the liberation of soluble FKN occurs in
the dorsal horn only when microglia are in a reactive state, with
electrical stimulation of primary afferent fibers under naive condi-
tions insufficient to induceFKN liberation (Clark et al., 2009). Thus,
as with the short-term plasticity described here, FKN liberation in
vivo requiresmicroglia reactivity, with neuronal activity alone being
insufficient. Consistently, inhibition of CatS/FKN/CX3CR1 atten-
uates neuropathic and inflammatory pain hypersensitivity (Mil-
ligan et al., 2004; Clark et al., 2007, 2012; Zhuang et al., 2007;
Staniland et al., 2010). Critically, we now demonstrate that solu-
ble FKN-induced activation ofmicroglial CX3CR1 is sufficient to
modulate synaptic transmission in the dorsal horn; thus, micro-
glial cells are capable of inducing synaptic facilitation in the ab-
sence of enhanced neuronal activity. Indeed, such a situation may
occur in vivo followingmicroglia-activating stimuli in the absence of
direct neuronal injury, such as during infection or neuroinflamma-
tion. Under such circumstances, the continuous presence of FKN
wouldmaintain facilitation by continuously drivingmicroglia reac-
tivity, and thereby enhancing nociceptive transmission.
In summary, we demonstrate a previously undescribed form of
short-termplasticity, wherebymicroglial cell activity is sufficient for
synaptic facilitation. Such a pronociceptive mechanism would con-
tribute to neuron–microglia positive feedback during chronic pain
andwould reinforce theproposal thatCX3CR1 receptor antagonists
would be beneficial for chronic pain treatment.
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